A 70-year-old white male, who had been diagnosed with IgA lambda multiple myeloma 4 months previously, was referred to the Mayo Clinic for further evaluation of anemia. The patient had required ...

GSK is carving out a niche for Blenrep in the second-line multiple myeloma setting, for which it projects a multi-blockbuster ...

Braunstein, MD, PhD, FACP, and hematology/oncology fellow Olivia Main, MD, talk about their choices for a patient with ...

Multiple myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...

4, 2024 — A new study shows strong alignment between real-world outcomes and those seen in clinical trials among a broad population of patients with relapsed or refractory multiple myeloma.

A multiple myeloma diagnosis is a life event that can be overwhelming. Get trusted information for every step of your journey. Multiple myeloma can be tricky. That’s because it sometimes has no ...

It is important to note that multiple myeloma can also lead to the development of other related conditions, such as monoclonal gammopathy of undetermined significance (MGUS), plasmacytoma ...

The department used its new system for determining whether a condition is service-connected to give affected veterans access ...

Due to major advances in understanding the biology and pathogenesis of the disease, the management of multiple ... myeloma patients. The book covers all myeloma subtypes and related disorders, ...

Nammi Therapeutics has commenced the first in-human Phase I trial of QXL138AM by dosing the first subject for treating ...

Diagnosis Gastrointestinal plasmacytoma. Management Control of underlying disease (multiple myeloma) with 2 cycles of treatment with melphalan and prednisone followed by high-dose pulse ...

Multiple Myeloma (MM) is an incurable blood cancer, leading to weakened immunity, bone damage, and other serious health ...